Li Juan

21PUBLICATIONS
31CO-AUTHORS
Predictive and prognostic markersMedical virologyMedical mycologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jul 26, 2026
Risk stratification, treatment patterns and survival outcomes in newly diagnosed multiple myeloma patients: A real-world analysis from the Chinese Myeloma Committee.

|Jun 12, 2026
Clinical implications and predictors of MRD resurgence in ASCT-eligible patients with NDMM: a real-world study in China.

|May 27, 2026
Sustained MRD Negative for 4 Years Is a Significant Marker of Prognosis in Patients with High-Risk Multiple Myeloma.

|May 10, 2026
Outcomes Among MM Patients Receiving Early Intervention for MRD Progression Following Autologous Stem Cell Transplantation.

|Nov 03, 2025
Impact of early minimal residual disease assessment on the outcomes of patients with systemic light chain amyloidosis.

Xiaozhe Li, Meilan Chen, Junru Liu

|Aug 01, 2025
The bone marrow immune ecosystem shapes daratumumab acquired resistance in plasma cell myeloma.

Yun Wang, Shuzhao Chen, Zhijian Liang

Pageof 4

Frequent Collaborators

4 joint publications

Junru Liu

3 joint publications

Juan Du

2 joint publications

Yuan Jian

2 joint publications

Zhiyao Zhang